Radic8 Viruskiller Hextio

Radic8 Viruskiller^TM technology was funded in 2004 by the Korean Government in response to SARS. The VirusKiller™ technology, which combines air purification and photocatalytic oxidation, is now in over 80% of all hospitals and schools in South Korea with over 370,000 installations.

Radic8 technology uses a two-stage process: filtration followed by photocatalytic oxidation technology. The Viruskiller™ Technology has a 99.9999% kill rate–in a single pass–against viruses similar to SARS-CoV-2 or harder-to-kill, such as Coronavirus DF2, Adenovirus, Influenza virus, and Poliovirus.

Viruskiller™ technology has 14 patents granted in South Korea and won Top Innovation Company Award in 2018 for Infection Control as determined by InfectionControl.tips.

 Hextio by Radic8:

• Designed for reception desks and small offices
• Covers spaces up to 215 square feet*
• 99.9999% kill rate in a single air exchange
• Tested against Coronavirus DF2, Adenovirus, Influenza virus, and Poliovirus
• Technology combines a pre-filter, HEPA filter, and activated carbon
• Compact, powerful and portable
• Low running costs

*Assuming 8' ceiling

This product is not FDA cleared or approved. Marketed under FDA’s Enforcement Policy for Air Purifiers, during the COVID-19 public health emergency. Tested on viruses that are representative of SARS-CoV-2, but not SARS-CoV-2 itself. This product has not been tested on SARS-CoV-2. This product is for medical purposes and should be used as an adjunct to personal protective equipment (PPE) and other infection control procedures. When using Viruskiller™, basic safety precautions should be observed, and instructions should be read to reduce the risk of fire, electric shock, or injury; the appliance should not be used by children or adults with reduced capabilities. Looking directly at an ultra-violet light may cause permanent damage to the eyes. Please visit https://henryscheindigital.com/radic8